Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Tremblay

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Blood Advances|February 21, 2020
The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosisLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Inflammatory Bowel Diseases|March 19, 2020
The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel DiseaseLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Virology|February 15, 2005
Cell wall localization of Red clover necrotic mosaic virus movement protein is required for cell-to-cell movementDouglas Tremblay, Andrew A Vaewhongs, Katherine A Turner, et al.
International Journal of Molecular Sciences|April 13, 2024
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease ProgressionJoseph Tripodi, Ronald Hoffman, Douglas Tremblay, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2024
Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapyMargaret Shyu, Angela Liu, Anya Srikureja, et al.
Blood Advances|December 4, 2020
Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burdenDouglas Tremblay, Ruben Mesa, Bart Scott, et al.
Journal of Medical Virology|July 25, 2020
Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort studyMaaike van Gerwen, Mathilda Alsen, Christine Little, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2017
Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experienceDouglas Tremblay, Vaibhav Patel, Kenneth M Fifer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 27, 2020
The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosisDouglas Tremblay, Leonard Naymagon, Kevin Troy, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 2, 2021
The utility and complications of plasma administration in cirrhotic patients undergoing minimally invasive proceduresKelly E Diaz, Douglas Tremblay, Begum Ozturk, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Blood Advances|February 21, 2020
The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosisLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Inflammatory Bowel Diseases|March 19, 2020
The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel DiseaseLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Virology|February 15, 2005
Cell wall localization of Red clover necrotic mosaic virus movement protein is required for cell-to-cell movementDouglas Tremblay, Andrew A Vaewhongs, Katherine A Turner, et al.
International Journal of Molecular Sciences|April 13, 2024
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease ProgressionJoseph Tripodi, Ronald Hoffman, Douglas Tremblay, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2024
Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapyMargaret Shyu, Angela Liu, Anya Srikureja, et al.
Blood Advances|December 4, 2020
Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burdenDouglas Tremblay, Ruben Mesa, Bart Scott, et al.
Journal of Medical Virology|July 25, 2020
Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort studyMaaike van Gerwen, Mathilda Alsen, Christine Little, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2017
Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experienceDouglas Tremblay, Vaibhav Patel, Kenneth M Fifer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 27, 2020
The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosisDouglas Tremblay, Leonard Naymagon, Kevin Troy, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 2, 2021
The utility and complications of plasma administration in cirrhotic patients undergoing minimally invasive proceduresKelly E Diaz, Douglas Tremblay, Begum Ozturk, et al.
Pageof 11